Introduction
============

Dimethyl sulfoxide (DMSO) is a polar aprotic solvent that is easily miscible with both aqueous and organic media because of its amphipathic nature.[@B1] It is frequently used in a wide range of biological studies, and its function has been investigated in various contexts; however, its molecular mechanisms have not been clearly defined. DMSO is able to dissolve numerous weakly polar and nonpolar compounds, and is therefore considered as an efficient solvent of water-insoluble compounds in biological test media.[@B3] It is often employed as a vehicle for drug therapies.[@B4]-[@B6] In addition, it is frequently used as cryoprotectant for cultured cells owing to its membrane penetration and water displacement properties.[@B7] DMSO has been used in the medical field to treat various conditions, including rheumatologic diseases, pulmonary adenocarcinoma, chronic prostatitis, dermatologic diseases, musculoskeletal disorders, schizophrenia, traumatic brain edema, and gastrointestinal diseases.[@B8]-[@B16]

So far, there are limited studies demonstrating the toxicity of DMSO in embryonic development. Since DMSO is the most commonly used as a cryoprotectant for freezing of oocytes and embryos for storage purposes, we propose that it is imperative to understand its biological effects on the developmental competence of mammalian embryos both *in vitro* and *in vivo*; this remains a major concern in toxicological studies.[@B17]-[@B19] Recently, Zhou et al. demonstrated that DMSO treatment affected the asymmetric division of mouse oocytes.[@B20] Detrimental effects of DMSO have also been reported in the development of both rat and zebrafish embryos.[@B21]-[@B23] In another study, Pal et al. evaluated the effect of DMSO on the development and differentiation potential of human embryonic stem cells (hESCs).[@B24] They showed that DMSO induced a dose-dependent (0.01-1%) reduction in cell viability and down-regulation of key marker genes associated with stemness, ectoderm, mesoderm, and endoderm, indicating an aberrant and untimely differentiation trajectory.

Oxygen radicals play an important role in embryonic development, particularly low oxygen content and superoxide dismutase (SOD).[@B25] DMSO plays a dual role either as a pro-oxidant or anti-oxidant depending on the concentration and cell type.[@B26]-[@B28] For instance, DMSO reduced arsenite- or hydrogen peroxide (H~2~O~2~)-induced intracellular reactive oxygen species (ROS) production in human-hamster hybrid and mouse embryonic cells.[@B26], [@B27] On the other hand, Sadowska-Bartosz et al. reported that DMSO induced oxidative stress in yeast cells in a dose-dependent manner by enhancing the loss of succinate dehydrogenase and enhancing the formation of reactive oxygen species (ROS).[@B28]

Autophagy is a process by which cytoplasmic components, including macromolecules and organelles, are degraded by the lysosome; it is considered as a defense strategy against environmental stress.[@B29] The earliest autophagic event in mammalian development was observed in fertilized oocytes.[@B30] Autophagy occurs at low levels in unfertilized oocytes, but is massively induced within 4 h of fertilization; both of maternal mRNAs and proteins are rapidly degraded after the 2-cell stages.[@B30] For example, it is well documented that autophagy-related 5 (Atg5)-nulled embryos failed to develop beyond the 4- and 8-cell stages.[@B31] In addition, mitophagy is a critical process to maintain the quality of mitochondria and to regulate mitochondrial number; this is done by selective engulfment of damaged mitochondria by autophagosomes, which are subsequently catabolized by lysosomes in response to the loss of mitochondrial membrane potential.[@B32] Like autophagy, mitophagy serves a protective role in limiting cell death.

The present study aimed to investigate the impact of DMSO on mouse pre- and post-implantation embryos, as there are currently no reports investigating this. The first objective of our study was to investigate the effect of DMSO on oxidative stress responses and its mechanistic role in the embryo. The second objective was to evaluate the effect of DMSO on endoplasmic reticulum (ER) stress, mitochondrial calcium accumulation, and induction of autophagy and mitophagy. The final objective was to determine the adverse effects of DMSO on pre- and post-implantation embryos.

Results
=======

Effects of DMSO on oxidative stress and calcium aggravation in mouse zygotes and embryos
----------------------------------------------------------------------------------------

First, we checked the effects of different concentrations of DMSO (0%, 0.5%, 1%, and 2% v/v) on the developmental competency of preimplantation embryos. Treatment with 0.5% DMSO did not significantly affect embryo development until the blastocyst stage. In 1% DMSO-treated groups, there was no significant change in embryo development until the 8-cell stages, but we observed \~31% inhibition at the morula stage and 59% inhibition at the early blastocyst stage compared to control groups**.** However, in 2% DMSO supplemented groups, significant developmental inhibition was observed from the 2-cell stages; no morulas or blastocysts were formed (**Fig. [1](#F1){ref-type="fig"}A, Movie [S1](#SM0){ref-type="supplementary-material"}**).

Mouse embryos are sensitive to the osmolarity of potassium simplex optimized medium (KSOM), which appears to be one of the major factors affecting developmental arrest at the 2-cells stage and survival of blastocysts.[@B33]-[@B35] We therefore investigated whether DMSO affects osmolarity of KSOM at each dosage of DMSO. As shown in **Fig. [1](#F1){ref-type="fig"}B**, the osmolarity of KSOM significantly increased from 224 to 328, 384, and 557 milliosmole (mOsm) when supplemented with 0%, 0.5%, 1%, and 2% DMSO, respectively. No morulas or blastocysts formed in the 2% DMSO-treated group, indicating that increased osmolarity of KSOM due to DMSO treatment might influence embryonic developmental capability.

Next, we checked the effects of DMSO on oxidative stress in zygotes. When zygotes were exposed to DMSO for 30 min, the production of intracellular ROS increased in a dose-dependent manner and was maintained for up to 2 h **(Fig. [1](#F1){ref-type="fig"}C)**: ROS levels were significantly higher in DMSO-treated groups (Type B) than in control groups (Type A), especially in the cytosol and perinuclear region **(Fig. [1](#F1){ref-type="fig"}D)**. Notably, ROS were found to accumulate in uncommonly high concentrations inside abnormally aggregated organelles of a few embryos from the 2% DMSO treated group (Type C) **(Fig. [1](#F1){ref-type="fig"}D)**. At the same time, mRNA levels of pro-oxidant genes (*Nox1*, *Nox2*, *Nox3*, *Nox4*, *Duox1*, *Duox2*, *Ncf1*, *Ncf4*) were markedly up-regulated in DMSO-treated groups, while mRNA levels of some anti-oxidant genes (*Gsr*, *Gpx3*, *Sod2*) were also considerably up-regulated **(Fig. [1](#F1){ref-type="fig"}E)**. On the other hand, the mRNA expressions of anti-oxidant genes such as *Gpx1* and *Gpx2* were down-regulated in DMSO-treated groups. In the case of *Sod1*, mRNA expression level decreased in the 0.5% DMSO-treated group, but increased when treated with higher doses of DMSO **(Fig. [1](#F1){ref-type="fig"}E)**.

Most zygotes treated with DMSO for over 24 h developed to the 2-cell stages. ROS levels increased in the perinuclear region and nucleus in a dose-dependent manner **(Fig. [1](#F1){ref-type="fig"}F)**. We also checked the mitochondrial calcium levels in the 2% DMSO-treated groups using Rhod-2 AM (a selective indicator for mitochondrial Ca^2+^). A substantial increase in fluorescence density was detected in the perinuclear region, where mitochondria are densely located. Interestingly, when the development of the 2-cell embryos was arrested after co-culture for 36 h with 2% DMSO, we observed a strong punctate accumulation of calcium in the perinuclear region **(Fig. [1](#F1){ref-type="fig"}G & H)**. Taken together, these results suggest that 1- to 2-cell embryos exposed to DMSO show increased oxidative stress; this effect endured until development to 2-cell embryos. DMSO exposure especially disrupted the balance of pro- and anti-oxidant gene expression, leading to increased oxidative stress and Ca^2+^ levels in the mitochondria.

Effects of DMSO on mitochondria-mediated apoptosis, ER stress, and developmental arrest in embryos
--------------------------------------------------------------------------------------------------

Immunostaining analyses were performed to determine the effects of DMSO on mitochondria-mediated apoptosis in 2-cell embryos exposed to 2% DMSO for 24 h. DMSO exposure induced the translocation of phosphorylated p53 (a pro-apoptotic marker) from the cytosol to the nucleus **(Fig. [2](#F2){ref-type="fig"}A)**, and decreased the expression of Bcl-2 (an anti-apoptotic protein) **(Fig. [2](#F2){ref-type="fig"}B)**. On the other hand, the expression of BAX (a pro-apoptotic marker) was markedly increased in the mitochondrial location of the perinuclear area **(Fig. [2](#F2){ref-type="fig"}C).** As a result, DMSO exposure resulted in increased CYSC/cytochrome C expression**(Fig. [2](#F2){ref-type="fig"}D)**. However, the mitochondrial membrane potential was decreased, as seen by the increased ratio of JC-1 aggregates to monomers in the 2-cell embryos and arrested embryos**(Fig. [2](#F2){ref-type="fig"}E)**. The occurrence of cellular apoptosis was further supported by the comet assay, a technique frequently used to check DNA fragmentation in apoptotic cells by measuring the tail length. The tail length in 2% DMSO-treated embryos was significantly higher than in control groups, confirming apoptosis in 2-cell embryos**(Fig. [2](#F2){ref-type="fig"}F).** Taken together, the induction of apoptosis by DMSO is inextricably linked to mitochondrial disruption. Therefore, the increased CYSC/cytochrome C expression may induce apoptosis through a caspase protein cascade, a caspase-dependent pathway, indicating that DMSO induces translocation of phosphorylated p53 from the cytosol to the nucleus and increases expression of CYSC/cytochrome C in the perinuclear region and induces their translocation to the nucleus.

When we checked the developmental rate and cleavage of zygotes during *in vitro* culture after exposure to DMSO for 48 h, we found that embryo cleavage was significantly retarded in DMSO-treated groups in a dose-dependent manner, starting from 1% DMSO **(Fig. [2](#F2){ref-type="fig"}G)**. Interestingly, approximately 32% and 20% of embryos in the 2% DMSO-treated groups are arrested at the 2- and 4-cell stages, respectively; however, in 0.5-1% DMSO-treated groups, significant developmental arrest was observed only at the 4-cell stages **(Fig. [2](#F2){ref-type="fig"}G)**. Furthermore, immunostaining analysis with anti-PDI antibody showed that DMSO caused aggregation of the ER in the cytosol of 2-cell embryos that were arrested after co-culture with DMSO for 36 h **(Fig. [2](#F2){ref-type="fig"}H)**. The effect of ER stress in embryos due to the exposure of DMSO was also analyzed by checking the expression levels of ER stress-related genes: all gene\'s expressions analyzed in this study were found to be significantly up-regulated in the 2% DMSO-treated group **(Fig. [2](#F2){ref-type="fig"}I)**. Collectively, DMSO-triggered oxidative stress causes ER stress and induces apoptosis via mitochondrial membrane depolarization, and consequently inhibits development of the embryo from 2-cells to 8-cells.

Effects of DMSO on the induction of mitophagy and autophagy in 2-cell embryos
-----------------------------------------------------------------------------

Mitophagy or autophagy can be formed as a defense strategy against environmental stress and serve a protective role in limiting cell death.[@B36], [@B37] We hypothesized that DMSO-induced cellular stress could activate mitophagy and autophagy in preimplantation embryos. In order to examine our hypothesis, we performed immunostaining of PINK1 and Parkin, which are the main mediators of mitophagy---i.e., autophagy of damaged mitochondria.[@B38]-[@B41] The embryos treated with 2% DMSO showed a considerable increase in mitophagy induction; this was evident from the increased localization of PINK1 and Parkin in the mitochondria, whereas untreated embryos exhibited stable expression of PINK1 and Parkin in the cytosol **(Fig. [3](#F3){ref-type="fig"}A, B)**.

To further monitor autophagy and mitophagy induction, we followed the expression of MAP1LC3B, which is essential for mature autophagosome formation.[@B42] Embryos treated with 2% DMSO showed enhanced expression of MAP1LC3B in mitochondria in discrete, punctate structures, indicating increased autophagosome formation **(Fig. [3](#F3){ref-type="fig"}C).** Since autophagosomes containing abnormal intracellular proteins or damaged organelles are subject to fusion with the lysosome for hydrolysis, we measured the lysosomal content in the embryos by immunostaining with LAMP1, a type I transmembrane glycoprotein that is primarily localized in lysosomes and late endosomes. After treatment with 2% DMSO, LAMP1-positive signals were observed in high amounts, indicating the recruitment of large numbers of lysosomal vesicles **(Fig. [3](#F3){ref-type="fig"}D)**. DMSO-triggered autophagy induction has also been confirmed by the dose-dependent up-regulation of various gene expressions involved in autophagy, such as *Itpr1*, *Atg4*, *Atg5*, *Becn1*, *Atg7,* and *Map1lc3b* **(Fig. [3](#F3){ref-type="fig"}E)**. An increase in lysosomal vesicles and their contents might play a role in autolysis; our data demonstrate that the fusion of the autophagosome and lysosome in DMSO-treated embryos occurred frequently **(Fig. [S1](#SM0){ref-type="supplementary-material"})**, indicating that DMSO exposure causes mitophagy and extensive autophagy in 2-cell embryos.

Effects of DMSO-induced oxidative/ER stress and calcium accumulation on morula to blastocyst stage embryo development
---------------------------------------------------------------------------------------------------------------------

To determine the further consequences of DMSO supplementation on the development of morulae to blastocyst stage embryos, zygotes were cultured in the presence or absence of 1% DMSO for 96 h. Representative photographs of blastocysts developed from morula stage embryos were taken by time-lapse photography under a microscope during *in vitro* culture **(Fig. [4](#F4){ref-type="fig"}A)**. The addition of 1% DMSO delayed expanded blastocyst development and exhibited two distinct abnormal patterns: (i) cavities were formed, but not fully grown; and (ii) embryos were still arrested in the morula stage after 96 h. Therefore, we checked whether DMSO could induce oxidative/ER stress or calcium accumulation and mitochondrial dysfunction in morula stage embryos, as in 1- to 2-cell stage embryos. We observed that 1% DMSO supplementation caused a substantial increase in ROS levels in morula stage embryos **(Fig. [4](#F4){ref-type="fig"}B)**.

Next, we examined mitochondrial function using MitoTracker^®^ Orange CMTMROS, which are effective tools to evaluate mitochondrial integrity. As shown in **Fig. [4](#F4){ref-type="fig"}C**, we observed a considerable decrease in fluorescence density in 1% DMSO-treated embryos; this was caused by decreased internalization of the MitoTracker^®^ Orange CMTMROS into mitochondria, indicating mitochondrial dysfunction or loss of mitochondrial membrane potential. We also examined the ultra-structure of mitochondria in both control and 1% DMSO-treated morula stage embryos. DMSO-treated morulae showed an increased number of swollen mitochondria compared to control embryos **(Fig. [4](#F4){ref-type="fig"}D)**. In addition, the mitochondrial DNA copy numbers in 0.5% and 1% DMSO-treated morulae were significantly increased **(Fig. [4](#F4){ref-type="fig"}E)**. Notably, the expression of genes such as *Mpv17*, *Cbr1*, *Immp1l*, *Mtfp1*, *Rhot2*, *Cycs*, *Atp5a1*, *Atp5e*, *Atp5d*, *Atp5k*, and *Atp5f1*, which have roles in maintenance of mitochondrial morphology, distribution, activity, and function, were considerably dysregulated in 1% DMSO-treated embryos **(Fig. [4](#F4){ref-type="fig"}F)**. However, the expression of these genes was substantially up-regulated in the 0.5% DMSO-treated group. This phenomenon may be transiently caused by a defense strategy to prevent embryo death due to environmental stress. Taken together, our results strongly indicated that exposure to 1% DMSO may result in severe mitochondrial damage and dysfunction, thus impeding or arresting further embryo development.

Mitochondrial Ca^2+^ levels in morula stage embryos were also significantly increased when exposed to 1% DMSO **(Fig. [4](#F4){ref-type="fig"}G).** We performed Western blot analysis to examine whether the onset of ER stress in morula stage embryos was caused by mitochondrial Ca^2+^ levels. As shown in **Fig. [4](#F4){ref-type="fig"}H**, Western blot analysis of ER stress marker proteins, including GRP78/BIP, showed a dose-dependent increase in protein expression after DMSO treatment. This clearly demonstrates that DMSO-induced early cellular stress responses, such as oxidative/ER stress and calcium accumulation, are still present in the morula stage embryos; as a result, these factors may result in developmental failure from morula stage embryos to blastocysts.

Effects of DMSO on mitophagic and autophagic responses in arrested morula stage embryos
---------------------------------------------------------------------------------------

To examine whether DMSO induced mitophagy and autophagy in arrested morula stage embryos, we analyzed the expression levels of known mitophagy marker proteins such as PINK1 and Parkin by immunostaining. Embryos treated with 1% DMSO showed an increase in mitophagy induction; this is evident from the increased localization of PINK1 and Parkin in mitochondria **(Fig. [5](#F5){ref-type="fig"}A, B)**. We further investigated PINK1 and Parkin protein, and mRNA expression levels. As shown in **Fig. [5](#F5){ref-type="fig"}C and D**, the mRNA and protein expression levels of PINK1 and Parkin were significantly increased after exposure to 1% DMSO. Furthermore, TOM20 expression was increased in the 0.5% DMSO-treated group compared to the control group; however, the 1% treatment group showed a lesser increase in expression than the 0.5% treatment group. **(Fig. [5](#F5){ref-type="fig"}D)**. Taking the data of **Fig. [4](#F4){ref-type="fig"}F** together, this phenomenon in the 0.5% treatment group may be transiently caused by regeneration of healthy mitochondria for survival against DMSO-induced acute cell stress. In addition, we examined p38 MAPK expression, which is an important regulator of mitophagy,[@B43] and found that p38 MAPK is increasingly phosphorylated in a dose-dependent manner after DMSO exposure **(Fig. [5](#F5){ref-type="fig"}E**). This indicates that embryos exposed to excessive doses of DMSO (1% or 2%) may be significantly damaged by severe mitochondrial dysfunction.

Next, we determined the expression levels of MAP1LC3B-I and MAP1LC3B-II by immunostaining and Western blot analysis. Both results demonstrated a dose-dependent increase in the expression of MAP1LC3B-II **(Fig. [5](#F5){ref-type="fig"}G, J)**. Even though the expression levels of MAP1LC3B-I after long-term exposure could be detected, the expression levels of MAP1LC3B-I after short-term exposure (within 1 min) were not detected in both control and DMSO-treated groups. The lysosomal contents of the embryos were also measured by immunostaining with LAMP1. We found a dose-dependent increase in LAMP1-positive signals, indicating the recruitment of large numbers of lysosomal vesicles **(Fig. [5](#F5){ref-type="fig"}H)**. Because autophagy can be induced by the up-regulation of IP3R1, ATG4, ATG5, Beclin-1, ATG7 and MAP1LC3B,[@B44] we performed Western blot and reverse transcription quantitative PCR (RT-qPCR) analysis of autophagy-regulated proteins including ATG5, Beclin-1, and SQSTM1/p62 in DMSO-treated morula stage embryos **(Fig. [5](#F5){ref-type="fig"}F, I).** The expression levels of these mRNAs and proteins were increased in a dose-dependent manner. These results indicate that developmental failure in morula stage embryos after exposure to DMSO may be caused by the induction of extensive autophagy and mitophagy.

Effects of DMSO on developmental competency of pre- and post-implantation embryos
---------------------------------------------------------------------------------

When we checked the developmental rate of blastocysts after DMSO exposure (0%, 0.5%, and 1%) at 96 h, we found that some blastocysts developed to a fully expanded state **(Fig. [6](#F6){ref-type="fig"}A)**. To investigate the quality of surviving blastocysts, we first checked the total number of cells---including the inner cell mass (ICM) and trophectoderm (TE) cells---in the blastocysts derived from zygotes, which were treated with 0.5% and 1% DMSO for 96 h. Immunoblotting with OCT3/4 and CDX2 showed that 1% DMSO treatment decreased the total number of cells---as well as ICM and TE cells---in blastocysts **(Fig. [6](#F6){ref-type="fig"}B)**. Furthermore, the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay showed a significant increase in the number of TUNEL-positive cells in blastocysts derived from 1% DMSO-treated zygotes **(Fig. [6](#F6){ref-type="fig"}C)**.

To determine the reasons behind developmental failure and subsequent poor quality blastocyst formation following DMSO exposure, we examined the expression levels of *Jnk*/*Atf2* mRNAs, which are genes involved in oxidative stress-induced apoptosis, as well as other genes involved in mitochondria-dependent apoptosis.[@B45], [@B46] We observed that DMSO exposure increased the mRNA expression levels of *Atf2*, *Mapk8*, and *Jun* in a dose-dependent manner **(Fig. [6](#F6){ref-type="fig"}D)**, indicating the activation of oxidative stress-responsive apoptosis signals. DMSO exposure also increased the mRNA expression levels of genes related to mitochondria-dependent apoptosis such as *Casp9*, *Casp3*, and *Trp53*, as well as the *Bax*/*Bcl2* ratio, in a dose-dependent manner **(Fig. [6](#F6){ref-type="fig"}D).**

Next, we analyzed the expression levels of genes correlated with the implantation potential, such as *B3gnt5*, *Eomes*, and *Wnt3a*, in the developed blastocysts following DMSO exposure. Treatment with 1% DMSO significantly decreased the mRNA expression levels of *B3gnt5*, which is involved in cell differentiation and adhesion of blastocysts **(Fig. [6](#F6){ref-type="fig"}E).**[@B47] Treatment with 0.5% DMSO significantly increased the mRNA expression levels of *Eomes*, which is involved in TE differentiation;[@B48] however, treatment with 1% DMSO did not show any effect **(Fig. [6](#F6){ref-type="fig"}E)**. It is well documented that the canonical WNT-CTNNB1 signaling pathway is critical for normal blastocyst function and implantation competency.[@B49], [@B50] Notably, DMSO exposure significantly decreased the mRNA expression levels of *Wnt3a*, but did not reduce the expression of *Wnt1*, *Lrp5*, or *Lrp6* **(Fig. [6](#F6){ref-type="fig"}E)**. The decrease in expression levels of both *B3gnt5* and *Wnt3a* in DMSO-treated blastocysts might be at least partially associated with nonviable implantation or pregnancy loss following implantation.

The effects of DMSO treatment on post-implantation embryos were also investigated after transferring the DMSO-treated blastocysts into the uteri of pseudopregnant mice. We found that treatment with 1% DMSO significantly decreased the implantation rate, the number of full-term pups, and the placental weight compared with control blastocysts **(Fig. [6](#F6){ref-type="fig"}F-H)**. The fetal length (crown-rump) and body weight were significantly decreased in 0.5% DMSO-treated groups **(Fig. [6](#F6){ref-type="fig"}H)**, but no change was observed in 1% DMSO-treated groups. All these findings indicate that DMSO treatment has negative effects on the developmental capability of pre- and post-implantation embryos.

Discussion
==========

The present study aimed to investigate the underlying mechanism of the cytotoxic effects of DMSO on mouse pre- and post-implantation embryos. For this purpose, mouse 1-cell zygotes were treated with DMSO at doses of 0%, 0.5%, 1%, or 2% (v/v) for 0.5-96 h to examine the effects of DMSO on (i) oxidative stress; (ii) ER stress, mitochondrial Ca^2+^ accumulation, mitochondrial dysfunction, autophagic and mitophagic responses; (iii) apoptosis-related signaling pathways; (iv) quality of blastocysts; (v) post-implantation development.

In this study, we determined that the osmolarity of KSOM supplemented with 0.5-2% DMSO increased to 328-557 mOsm, whereas the osmolarity of KSOM without DMSO was 224 mOsm **(Fig. [1](#F1){ref-type="fig"}B)**. Osmolarity of the culture medium is an important parameter for regulating the fate of early embryo development: osmotic stress leads to an influx or efflux of water into the cell; hypoosmotic stress causes swelling, whereas hyperosmotic stress causes shrinkage.[@B51] Therefore, before beginning our detailed investigation into the cytotoxic mechanisms of DMSO, we checked the immediate effects of DMSO on KSOM. Preimplantation embryos cultured in medium with an osmolarity higher than 300 mOsm do not normally progress to the blastocyst stage *in vitro*;[@B52] therefore, DMSO supplementation of zygotes cultured *in vitro* may experience hyperosmotic stress. As a result, the development of many embryos may be arrested at the 2-cell, 4-cell, or morula stages.

Generally, mitochondria are the main endogenous ROS producer. Also, another important generator of ROS is NOX, a family of membrane-bound proteins that transfer electrons from NADPH to O~2~.[@B53] From the seven isoforms of the *Nox* genes family identified in mammalian cells, we examined *Nox1*, *2*, *3*, and *4* mRNA expression, and found their levels were significantly increased in DMSO-treated groups compared to control (**Fig. [1](#F1){ref-type="fig"}E**). In *Nox4*-overexpressing HEK293 cells and endothelial cells, NOX4 continuously produces H~2~O~2~.[@B54]-[@B56], Moreover, NOX 4 activity has been closely linked to elevated *Nox 4* mRNA expression, indicating that NOX 4 directly targets *Nox 4* gene itself to regulate NOX4 activity. Since the dual oxidases (DUOX) have specialized domains for the dismutation of O~2~^-^, and produce H~2~O~2~ as substrate for peroxidation and other oxidation reactions, [@B57] we also examined *Duox1* and *Duox2* mRNA expression as well as glutathione synthetase*(Gss)*, *p40*, and *p47* mRNA expression in DMSO-treated groups. Expression of these mRNAs, like the *Nox* mRNAs, was significantly increased in DMSO-treated groups. Even though *Gpx1* and *2* mRNA expression in DMSO-treated groups was significantly decreased, expression of most antioxidant mRNAs, such as glutathione-disulfide reductase (*Gsr)*, superoxide dismutase (*Sod)1*, *Sod2*, and glutathione peroxidase*(Gpx)3*, were significantly increased. Dichotomous effects of antioxidant mRNA expression in DMSO-treated groups may be transiently caused by excessive and uncontrolled production of oxygen radicals due to excessive DMSO exposure or by activities of all the enzymes increased in response to the oxidative challenges, because physiological cellular ROS production under various stress conditions is an essential component of normal antioxidant production. Taken together, we concluded that mRNA expression of these pro-oxidants and anti-oxidants are closely correlated with the level of DMSO-induced oxidative injury to embryos. As a result, increased ROS levels persisted in embryos until the morula stage.

Osmotic and oxidative stress responses generally differ, but they displayed overlapping symptoms in some cases.[@B51] Generally, oxidative stress is caused either by the disturbance of the cellular redox state, which is composed of both enzymatic and non-enzymatic defense mechanisms, or by the accumulation of ROS (such as superoxide, hydrogen peroxide, and hydroxyl radicals) within the cell, which may cause molecular damage to DNA, proteins, cell membranes, etc.[@B51] Therefore, the oxidative stress response in DMSO supplemented embryos may cause more direct harm to the cell than osmotic stress. In mammalian embryos, excess ROS concentration is often associated with developmental arrest or damage *in vitro*.[@B58], [@B59] Previous studies have reported that 0.1% or 0.5% DMSO exposure reduced arsenite- or H~2~O~2~-induced ROS production in human-hamster hybrid and mouse embryonic cells.[@B26], [@B27] On the other hand, Sadowska-Bartosz et al.[@B28] reported that 1% DMSO exposure induced oxidative stress in yeast cells. Therefore, we have concluded that DMSO supplementation for culturing mouse zygotes play dual roles: either as a pro- or anti-oxidant, depending on the concentration of DMSO.

There are numerous studies related to the detrimental role of ER stress in oocyte maturation and early mammalian embryonic development.[@B60]-[@B63] Because *in vitro* developmental competence of mammalian embryos is highly dependent on the coupled/cooperative response between oxidative and ER stress (i.e., stress plays a key role in protein structural modifications that are essential for embryos to function correctly),[@B59] we examined ER stress. In the present study, we observed abnormally aggregated ER-positive signals in the perinuclear region of 2-cell arrested embryos that were cultured with 2% DMSO for 36 h (**Fig. [2](#F2){ref-type="fig"}H**). Furthermore, the induction of ER stress in 2-cell or morula stage embryos following DMSO supplementation was confirmed by analyzing the expression of ER stress-activated genes and/or proteins. As shown in **Fig. [3](#F3){ref-type="fig"}E**, RT-qPCR analysis showed that *Itpr1*, *Atg4b*, *Atg 5*, *Atg6*, *Atg7*, and *Atg* 8 mRNA expression levels in 2 cell embryos treated with DMSO were significantly increased in a dose-dependent manner, compared with those of the control group, whereas *Atg3* mRNA expression was significantly downregulated. MAP1LC3B-I can be converted to the MAP1LC3B-II form after being cleaved by a Cys-protease such as Atg-4, which is activated by ROS. This step is necessary for the action of Atg-7, which leads to Atg-5/Atg-12 conjugation and subsequent linkage to Atg16. These mRNA upregulations indicate that DMSO-induced autophagy required the classical autophagic machinery along with molecules involved in membrane extension of the autophagosomal membranes such as ATG7 and LC3. Even though it is unclear why *Atg3* mRNA expression in DMSO-treated groups is downregulated, downregulation of *Atg3* mRNA expression leads to accumulation of aberrant mitochondria, enhanced ROS generation, and defective ATP production (**Fig. [1](#F1){ref-type="fig"}A, C, F, 4B-F**). Therefore, we concluded that excessive accumulation of misfolded or unfolded proteins in the ER lumen generates ER stress, which ultimately results in substantial cellular damage, followed by apoptosis or degeneration.

The ER and mitochondria are physically and functionally closely linked. Therefore, Ca^2+^ release from the ER, which is the major intracellular Ca^2+^-storage organelle, has a direct effect on the physiological function of the mitochondria.[@B64] To assess the impact of DMSO-induced ER stress on mitochondria, we measured mitochondrial Ca^2+^ levels and the subsequent events leading to cell death in 2-cell or morula stage embryos. We observed that exposure to DMSO significantly increased the mitochondrial Ca^2+^ levels in early embryos, and also induced mitochondrial depolarization and dysfunction (**Fig. [1](#F1){ref-type="fig"}G-H, 2E, 4C-G**). Transmission electron microscopy (TEM) analysis demonstrated that most of 1% DMSO-treated morula stage embryos showed significantly swollen mitochondria when compared with control embryos (**Fig. [4](#F4){ref-type="fig"}D**), indicating severe mitochondrial damage. Furthermore, DMSO-treated 2-cell embryos showed a decrease in expression of the anti-apoptotic protein Bcl-2, translocation of phosphorylated p53 (a pro-apoptotic marker) from the cytosol to the nucleus, as well as a considerable increase in BAX expression, indicating that arrested 2-cell or morula stage embryos might experience mitochondria-dependent apoptosis.

Treatment with DMSO significantly reduced ICM and TE cell numbers in blastocysts, indicating a high likelihood of pregnancy loss following implantation. We also found that DMSO significantly decreased the expression of *B3gnt5* and *Wnt3a* in the blastocysts (**Fig. [6](#F6){ref-type="fig"}E**). To determine the underlying mechanism, we counted fetus numbers after transferring the blastocysts into the uteri of pseudopregnant mice. DMSO treatment significantly decreased the implantation rate and the number of full-term pups compared to control blastocysts (**Fig. [6](#F6){ref-type="fig"}F, G**). Detrimental effects are linked to blastocysts with decreased *Wnt3a* and *Eomes* gene expression, which generally experienced spontaneous pregnancy loss (absorption), while blastocysts with decreased *B3gnt5* and *Eomes* gene expression generally failed to implant.[@B65]

Another important adaptive response commonly induced to combat ER stress is autophagy.[@B66] Interestingly, disturbance of either ER function or ER calcium homeostasis triggers autophagy and apoptotic cell death.[@B67] However, the effect of autophagy on cell survival against ER stress is not always clear and depends on the tissue type. Ding et al.[@B68] demonstrated that ER-induced autophagy is important in mitigating ER stress-induced cell death in colon and prostate cancer cells; on the other hand, autophagy does not confer protection, but rather contributes to ER-induced apoptosis in non-transformed murine embryonic fibroblasts and in normal human colon cells. Our laboratory recently showed that treating mouse preimplantation embryos with the autophagy activator rapamycin significantly abrogated the chitosan-induced ER stress response and subsequent detrimental effects on development.[@B69] In our present study, we observed that DMSO-induced ER stress triggered mitophagy and autophagy in 2-cell or morula stage embryos (**Fig. [2](#F2){ref-type="fig"}A-E, 5A-I**). Mitophagy induction was confirmed by increased localization of PINK1 and Parkin, which are the main mediators of mitophagy, in mitochondria.[@B38]-[@B41]

Parkin promotes mitophagy in two different ways. In the first mechanism, Parkin causes the degradation of its substrates, Miro and Mitofusin, through ubiquitin-ligase activity.[@B70] Miro and Mitofusin are phosphorylated by PINK1 prior to Parkin-dependent degradation.[@B70] Proteasomal degradation of Miro and Mitofusin prevents mitochondrial movement, quarantines damaged mitochondria, and promotes their clearance by autophagosomal engulfment.[@B70] Alternatively, Parkin-mediated outer mitochondrial membrane protein ubiquitination is recognized by ubiquitin-binding adaptor proteins such as SQSTM1/p62, which accumulate on depolarized mitochondria and facilitate the recruitment of damaged mitochondria to autophagosomes through interactions with MAP1LC3B-II.[@B30], [@B69], [@B70] In this study, DMSO treatment caused a dose-dependent increase in the expression of several genes/proteins involved in autophagy initiation, phagophore elongation, and autophagosome formation, indicating an increase in autophagosome formation and accumulation (**Fig. [3](#F3){ref-type="fig"}, 5**). Furthermore, we investigated autolysosomal maturation and degradation by analyzing the expression levels of SQSTM1/p62, which is normally degraded by autolysosomes after incorporation into autophagosomes via direct binding to MAP1LC3B-II.[@B71], [@B72] Unsurprisingly, we observed that DMSO treatment resulted in a dose-dependent increase in the expression of SQSTM1/p62, indicating impaired autophagosomal maturation and degradation. The autophagosome accumulation observed in DMSO-treated embryos was mainly caused by blockage of autophagic flux, rather than by induction of autophagy. There have been several reports demonstrating that blockage of autophagic flux or impaired autophagic degradation is associated with cell death.[@B73], [@B74] Therefore, our results indicate that the cytotoxic effects of DMSO in preimplantation embryos are caused, at least in part, by the blockage of autophagic flux.

To assess whether withdrawing DMSO supplementation could rescue DMSO-mediated embryo toxicity, we transferred DMSO-exposed embryos into fresh KSOM medium. As shown in **Fig. [S2](#SM0){ref-type="supplementary-material"}**, we found that withdrawing 2% DMSO supplementation within 24 h significantly increased embryonic survival and hatching rates, decreased apoptosis, and ameliorated abnormal development of mouse embryos exposed to DMSO. However, embryos exposed to DMSO longer than 48 h showed markedly inhibited developmental competency at both 1% or 2% DMSO concentrations, indicating that both of exposure time and DMSO concentration are critical factors for embryonic developmental arrest.

In conclusion, DMSO treatment resulted in mitochondria-dependent apoptosis in mouse preimplantation embryos: this may be due to the induction of oxidative/ER stress, mitochondrial Ca^2+^ overload, or blockage of autophagic flux (**Fig. [6](#F6){ref-type="fig"}I, J**). DMSO also disrupted the expression of genes associated with blastocyst developmental competence and consequently decreased the implantation rate and the number of full-term pups. To the best of our knowledge, this is the first report to study the underlying mechanisms of DMSO-induced cytotoxicity in mouse preimplantation embryos. Therefore, our experimental findings will provide a significant contribution to finding effective protective agents to combat DMSO-mediated reproductive toxicity for application in human embryos in the near future.

Materials and Methods
=====================

Animals
-------

Mice were housed in wire cages at 22±1 °C under a 12 h light-dark cycle with 50% humidity. All experiments were conducted in accordance with the Konkuk University Guide for the Care and Use of Laboratory Animals (IACUC approval number: KU15153).

Measurement of osmolarity in KSOM supplemented with DMSO
--------------------------------------------------------

DMSO (Sigma-Aldrich, D2650) was added to KSOM at concentrations of 0%, 0.5%, 1%, and 2% (v/v). Osmolarity levels in each group were determined using the Advanced® Model 3320 Micro-Osmometer (Advanced Instrument, 3320) according to the manufacturer\'s instructions. Briefly, 20 µL of each KSOM-DMSO mixture was aspirated by the sampler tip, and placed on the instrument\'s cradle. Measurements were determined automatically using the freezing point of the mixtures; each measurement was independently repeated three times.

Zygote collection and in vitro culture with DMSO supplementation
----------------------------------------------------------------

BDF1 mice (8-12 weeks) were used for collection of zygotes. Female mice were intraperitoneally injected with pregnant mare\'s serum gonadotropin (PMSG; 5IU), followed by human chorionic gonadotropin (hCG; 5IU) after 48 h; they were then mated with stud BDF1 male mice.[@B75] At 18 h post hCG injection, the zygotes were isolated from oviducts and washed in HEPES-modified Chatot-Ziomek-Bavister (CZB) medium containing hyaluronidase. Ten zygotes per group were then cultured in 20 µL of KSOM supplemented with 0%, 0.5%, 1%, or 2% DMSO and subjected to further study.

RNA extraction and gene expression analysis
-------------------------------------------

Total RNA was obtained from pools of ten embryos in each DMSO treatment group (0%, 0.5%, 1%, and 2%). RNA was added to 5 µL lysis buffer containing 0.3% IGEPAL® CA-630 (Sigma-Aldrich, I3021) and 0.1% BSA (Sigma-Aldrich, A3311), and then directly frozen-thawed in liquid nitrogen.[@B76] cDNA was synthesized from the RNA samples by using the QuantiTect^®^ Reverse Transcription Kit (Qiagen, 205313) in a final volume of 20 µL, according to the manufacturer\'s instructions. RT-qPCR was run three times on 2 µL of cDNA from each reaction using the SensiFAST™ SYBR Hi-ROX Kit (Bioline, BIO-92005) in the ViiA™ 7 Real-Time PCR System (Thermo Fisher Scientific, ABI ViiA 7). Using the 2-ddCt method by normalizing with *H2afz* mRNA expression, relative quantification was analyzed. Detailed genes and primers information is listed in **Table [S1](#SM0){ref-type="supplementary-material"}**.

Mitochondrial activity measurement
----------------------------------

Measurement of mitochondrial activity by fluorescence was performed as previously described.[@B77] Embryos were incubated in KSOM supplemented with 500 nM MitoTracker^®^ Orange CMTMROS (Thermo Fisher Scientific, M7510) for 10 min, then washed three times in KSOM. Embryos were fixed in 4% paraformaldehyde for 30 min and were either mounted on glass slides for observation under a confocal microscope, or used for additional immunostaining. The intensity of fluorescence signals indicating mitochondrial activity was analyzed using Image J software (<https://imagej.nih.gov/ij/>); relative fluorescence was compared between DMSO-treated and control groups.

Relative quantification of mitochondria
---------------------------------------

To quantify the number of mitochondria, morula stage embryos, which were cultured with DMSO supplementation at concentrations of 0%, 0.5%, and 1% for 72 h from zygotes, were collected using 5 µL lysis buffer \[125 μg/mL proteinase K, 100 mM Tris-HCl (pH 8.3), 100 mM KCl, 0.02% gelatin, 0.45% Tween 20\] then lysed by snap-freezing.[@B78] The mtDNA content was determined by comparing the ratio of mtDNA to nuclear DNA, as measured by real time PCR.[@B79] Specific mitochondria primer sets are listed in **Table [S1](#SM0){ref-type="supplementary-material"}**.

Immunofluorescence
------------------

Immunostaining was performed as previously described.[@B80] Next, embryos were incubated with primary antibodies overnight at 4 °C; secondary antibodies labelled with Alexa488, 568, or 647 were then used to mark the primary antibodies. DNA was stained using TO-PRO®-3 Iodide (Thermo Fisher Scientific, T3605). The embryos were mounted on glass slides using Vectashield® mounting medium (Vector Laboratories, H-1000) and observed under laser confocal microscopes (Olympus, FV1000 and Zeiss, LSM510). All primary antibodies used are summarized in **Table [S2](#SM0){ref-type="supplementary-material"}**.

TUNEL assay
-----------

TUNEL assay was performed on the embryos using the In Situ Cell Death Detection Kit, TMR Red (Sigma-Aldrich, 12156792910) according to the manufacturer\'s instructions. After labeling, the embryos were washed three times with 1% BSA-PBS solution, and stained using 4 μM TO-PRO-3 (Thermo Fisher Scientific, T3605) marking DNA. Embryos mounted on glass slides were observed under a laser confocal microscope (Olympus, FV1000). The number of total cells and labeled dead cells were analyzed using Image J software.

Measurement of mitochondrial membrane potential
-----------------------------------------------

To measure the mitochondrial membrane potential, embryos were incubated in KSOM supplemented with 2 μg/mL JC-1 Dye (Thermo Fisher Scientific, T3168) for 30 min at 37 °C in a 5% CO~2~ atmosphere, according to the manufacturer\'s instructions. After washing in KSOM twice, embryos were placed in a drop of HEPES-CZB media on a glass-bottomed cell culture dish and observed under a laser confocal microscope (Zeiss, LSM 510). Detected fluorescence signals were analyzed using Image J software.

ROS measurement
---------------

To visualize ROS levels by fluorescence, embryos were incubated with KSOM supplemented with 5 μM CellRox® Green Reagent (Thermo Fisher Scientific, C10444) for 30 min at 37 °C in a 5% CO~2~ atmosphere, according to the manufacturer\'s instructions. Embryos were then washed in 0.1% PVA-PBS buffer three times and fixed in 4% paraformaldehyde. They were then permeabilized in a 1% BSA-PBS solution containing 0.5% Triton-X 100 for 30 min. DNA was stained using 4 μM TO-PRO®-3 Iodide (Thermo Fisher Scientific, T3605), and embryos were mounted on glass slides. All images were obtained using a laser confocal microscope (Zeiss, LSM 510) and analyzed using Image J software.

Calcium level measurement
-------------------------

Calcium levels were determined by loading 5 μM Rhod-2 AM (Thermo Fisher Scientific, R1244) onto embryos treated with 0%, 0.5%, 1%, and 2% DMSO for 30 min at 37 °C in a 5% CO~2~ atmosphere, according to the manufacturer\'s instructions. After washing in PBS three times, the embryos were placed in a drop of HEPES-CZB media covered with mineral oil on a glass-bottomed confocal dish and observed under a confocal microscope (Zeiss, LSM510).

Comet assay
-----------

Two zygotes were cultured with DMSO for 24 h and analyzed using the OxiSelect™ Comet Assay Kit (Cell Biolabs, STA-351) according to the manufacturer\'s instructions. Briefly, embryos were combined with OxiSelect™ Comet Agarose at 37 °C and placed onto OxiSelect™ Comet slides to harden. Comet slides with embryo-agarose material were transferred to a small container containing pre-chilled lysis buffer and immersed for 30 min at 4 °C in the dark. After aspirating the lysis buffer, electrophoresis was performed using pre-chilled TBE buffer for 10-15 min at 20 V. Finally, the slides were stained using Vista Green DNA dye, and fluorescence was observed under a microscope (Olympus, BX51). Tail length was analyzed by the Open Comet Plugin (<http://www.cometbio.org/documentation.html>) using Image J software.[@B81]

Immunoblotting
--------------

Morulas were developed from zygotes by incubating in KSOM supplemented with 0%, 0.5%, and 1% DMSO for 72 h. Thereafter, embryos were pooled in 10 µL of radioimmunoprecipitation assay buffer (RIPA) Cell Lysis Buffer (GenDEPOT, R4100). Lysed samples were denatured by adding 2X Laemmli sample buffer (Sigma-Aldrich, S3401), followed by boiling at 95 °C for 10 min. Immunoblotting was then performed as previously described.[@B82] HRP-conjugated secondary antibodies were applied to recognize primary antibodies; SuperSignal™ West Femto Maximum Sensitivity Substrate (Thermo Fisher Scientific, 34095) was used to detect HRP, followed by visualization of chemiluminescence using X-ray film. Densitometry analysis was conducted using Image J software. All blotting bands were normalized using ACTB. Detailed information on antibodies is listed in **Table [S2](#SM0){ref-type="supplementary-material"}.**

TEM analysis
------------

Sample preparation of morulas for TEM was performed as previously described. [@B64] After embedding, the samples were sectioned using LKB-III ultratome (Leica, 8801A) with a serial ultrathin grade. Ultrathin sections were stained with uranyl acetate (Ted Pella, 19481) and lead citrate (Ted Pella, 19312) and examined using an electron microscope (Hitachi, H7600) at an accelerating voltage of 100 kV.

Embryo transfer and post-implantation analysis
----------------------------------------------

Blastocysts were developed from zygote by incubating with 0%, 0.5%, and 1% DMSO for 96 h. Thereafter, embryos were transferred into the uteri of 2.5 days postcoitus (dpc) pseudopregnant ICR mice as previously described.[@B75] Two days after embryo transfer, the implantation rate was detected by sacrificing recipient ICR mice, followed by an intravenous injection with Chicago Sky Blue 6B (Sigma-Aldrich, C8679) as previously described.[@B75] At 18.5 dpc, the full-term development rate was checked after cesarean section of the recipient mice. Placenta weight, body weight, and crown-rump size were evaluated for individual pups.

Data analysis
-------------

All experimental data are presented as the mean ± SEM. Each experiment was performed at least three times and subjected to statistical analysis. Results from three representative experiments are presented in all figures. For statistical analysis, one-way ANOVA was first performed to determine any differences among groups (\*: *p*\<0.05; \*\*: *p*\<0.01). Fisher\'s post hoc test was then performed to determine significant differences between pairs. Values of *p*\<0.05 and *p*\<0.01 were considered significant. Statistical tests were performed using Graph Pad Prism Software (<https://www.graphpad.com/scientific-software/prism/>).
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![**Effects of DMSO on oxidative stress and calcium accumulation during development from zygote to 2-cell stages.** (A) Developmental rate of mice preimplantation embryos after incubation with 0%, 0.5%, 1%, and 2% DMSO. (**B)** Osmolarity of KSOM supplemented with DMSO at different concentrations. **(C, D)** ROS levels in 2-cell embryos treated with different concentrations of DMSO for 30 min and 2 h respectively, and analysis of the fluorescence pattern in the cytosol. Scale bar, 50 μm. **(E)** Gene expression analysis of pro- and anti-oxidants by RT-qPCR in 1-cell embryos treated with different concentrations of DMSO for 30 min.**(F)** ROS levels were determined in 2-cell embryos after 24 h exposure to DMSO at different concentrations. Fluorescence intensity in the nucleus and perinuclear region was compared between groups. Scale bar, 50 μm. **(G, H)** Calcium levels were determined by analyzing Rhod-2 AM fluorescence in 2-cell embryos after 24 h and 36 h exposure to DMSO at different concentrations. Scale bar, 50 μm. Fluorescence intensity in the nucleus, perinuclear region, and cortical region was compared between groups. \*: *p*\<0.05, \*\*: *p*\<0.01.](thnov07p4735g001){#F1}

![**Effects of DMSO on mitochondria-mediated apoptosis, ER stress, and developmental arrest in 2-cell embryos. (A)** Phosphorylated p53 immunostaining showing translocation of the signal from the cytosol to the nucleus in the 2% DMSO-treated group. (**B, C)** Bcl-2 and BAX protein expression was detected by immunocytochemistry; fluorescence signals around the nucleus were compared between the control and 2% DMSO-treated groups. (**D)** CYCS/Cytochrome C immunostaining in 2% DMSO-treated embryos. (**E)** Mitochondrial depolarized membrane status was analyzed using JC-1 dye. Right graph shows the JC-1 aggregate to monomer ratio, which indicates the membrane potential status of the treated groups. (**F)** Comet assay in 2-cell embryos treated with 2% DMSO. Tail lengths were analyzed (bottom-right panel). Enlarged nucleus-stained pictures are shown in the bottom-left panel. (**G)** The developmental arrest ratio from 2-cell to 8-cell stages after 48 h of exposure to DMSO at different concentrations. **(H)** The ER was immunostained using anti-PDI antibody and fluorescence intensity was determined using confocal microscopy at the 2-cell stages after 24 h exposure to DMSO at different concentrations. **(I)** ER stress-related gene expression was analyzed using RT-qPCR and normalized with respect to the control group. \*: *p*\<0.05, \*\*: *p*\<0.01. Scale bar, 50 μm.](thnov07p4735g002){#F2}

![**Effects of DMSO on the induction of mitophagy and autophagy in 2-cell embryos. (A, B)** Immunostaining pattern of PINK1 and Parkin expression in 2-cell embryos exposed to 2% DMSO. The representative fluorescence intensities at the perinuclear region and nucleus are marked with a dotted-line box. **(C)** MAP1LC3B expression was detected by immunocytochemistry and co-localized with mitochondria using MitoTracker^®^ Orange CMTMROS in DMSO-treated embryos. Bottom graph shows the comparison of punctate area per embryo among groups.**(D)** Lysosomes were immunostained using anti-LAMP1 antibody in 2% DMSO-treated groups. Fluorescence intensities due to LAMP1 in the cytoplasmic and perinuclear regions were analyzed in the right graph. **(E)** RT-qPCR analysis of autophagy-related genes in DMSO-treated embryos. \*\*: *p*\<0.01.](thnov07p4735g003){#F3}

![**Effects of DMSO-induced oxidative/ER stress and calcium accumulation on morula to blastocyst stage embryo development after zygotes were developed to morula stage embryos following 72 h DMSO exposure.** (A) Time lapse images for morula to blastocyst transition with 4 h intervals. (B, C) In morulae, ROS levels and mitochondrial activities were measured and compared between DMSO-treated and control groups. Scale bar, 50 μm (D) TEM images of morulae in control and 1% DMSO-treated groups. Scale bar, 1 μm (E) Relative copy number of mitochondrial DNA in morulae treated with DMSO at different concentrations (F) RT-qPCR analysis of genes with a role in maintenance of mitochondrial morphology and distribution, as well as mitochondrial activity and function. (G) Calcium levels were checked after staining with Rhod-2 AM in morulae grown with different concentrations of DMSO. Scale bar, 100 μm (H) Immunoblot analysis of GRP78/BIP protein in morulae. \*: *p*\<0.05, \*\*: *p*\<0.01.](thnov07p4735g004){#F4}

![**Effects of DMSO on mitophagic and autophagic responses in arrested morula stage embryos. (A, B)** Immunostaining for PINK1 and Parkin in morulae exposed to 1% DMSO. Left and right panels show single and multiple projections, respectively. Scale bar, 20μm **(C)** RT-qPCR analysis of *PINK1* and *Parkin* mRNA expression in arrested morulae treated with 1% DMSO. **(D, E)** Immunoblot analysis of PINK1, Parkin, TOM20, p38 and phospho-p38 proteins in DMSO-treated morulae. (**F)** Real Time RT-qPCR analysis on genes related to autophagic induction. (**G)** MAP1LC3B expression was detected by immunocytochemistry and co-localized with mitochondria in the DMSO-treated embryos. Left and right panels show single and multiple projections, respectively. Scale bar, 20μm (**H)** Lysosomes were immunostained using anti-LAMP1 antibody in 1% DMSO-treated groups and co-localized with mitochondria using MitoTracker^®^ Orange CMTMROS in DMSO-treated embryos. Scale bar, 20 μm **(I)** Immunoblot analysis of ATG5, Beclin-1, and SQSTM1/p62 in morulae treated with DMSO at different concentrations. \*: *p*\<0.05, \*\*: *p*\<0.01. (**J**) MAP1LC3B-I and MAP1LC3B-II Western blotting analysis. Band intensities were quantified and then analyzed by Image J software. The experiments were independently repeated three times and β-Actin was used as a loading control. \*\*: *p*\<0.01.](thnov07p4735g005){#F5}

![**Effects of DMSO on developmental competency of pre- and post-implantation embryos. (A)** Images of blastocysts developed from zygotes supplemented with DMSO for 96 h. Scale bar, 100 μm**(B)** Inner cell mass (ICM)/trophectoderm (TE) specification in fully-grown blastocysts was analyzed using immunostaining with anti-OCT3/4 (green color) and anti-CDX2 (red color) antibodies. The number of cells in the ICM and TE are compared in the bottom graph. Scale bar, 50 μm**(C)** TUNEL assay of fully-grown blastocysts (96 h) after exposure to different concentrations of DMSO. The number of apoptosis-positive cells (red color) was compared between groups. Scale bar, 50 μm**(D)** RT-qPCR analysis of genes involved in the oxidative stress response and mitochondria-dependent apoptosis in fully grown blastocysts after exposure to different concentrations of DMSO for 96 h. **(E)** RT-qPCR analysis of genes that regulate implantation success in uterus. **(F)** Implantation rate in the uterus at 6.5 dpc after transferring blastocysts treated with DMSO at different concentrations. **(G, H)** Evaluation of the number of full-term pups at 18.5 dpc by cesarean section after transferring blastocysts to the uterus. Placenta weight, body weight, and size of the crown-rump of the pups. Scale bar, 1 cm **(I)** A representative hypothetical model for differential effects of DMSO on mouse preimplantation embryos. During *in vitro* growth of mouse zygotes to blastocyst stage embryos, exposure to different concentrations of DMSO greatly increased the osmolarity of KSOM, intracellular ROS levels, intracellular Ca^2+^ levels, ER stress, and autophagy/mitophagy numbers in developing preimplantation embryos; conversely, the mitochondrial function and developmental competency of preimplantation embryos were significantly decreased. After 1% or 2% DMSO supplementation, most embryos were arrested at the 2-cell, 4-cell, or morula stages. **(J)** Although some zygotes developed to the blastocyst stage after 1% DMSO supplementation, these blastocyst embryos showed decreased CDX2, OCT3/4, *B3gnt5*, and *Wnt3a* protein and gene expression. As a result, both implantation and full-term development rates were significantly reduced, compared to control group. \*: *p*\<0.05, \*\*: *p*\<0.01.](thnov07p4735g006){#F6}
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